nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC22A3—Estradiol—osteoporosis	0.235	0.844	CbGbCtD
Amphetamine—CYP2D6—Cholecalciferol—osteoporosis	0.0432	0.156	CbGbCtD
Amphetamine—Pseudoephedrine—NFATC1—osteoporosis	0.0103	0.768	CrCbGaD
Amphetamine—Lacosamide—CA2—osteoporosis	0.00189	0.141	CrCbGaD
Amphetamine—Pseudoephedrine—TNF—osteoporosis	0.0012	0.0902	CrCbGaD
Amphetamine—Somnolence—Calcitriol—osteoporosis	0.00118	0.00215	CcSEcCtD
Amphetamine—Decreased appetite—Ibandronate—osteoporosis	0.00118	0.00215	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00117	0.00213	CcSEcCtD
Amphetamine—Depression—Estradiol—osteoporosis	0.00117	0.00213	CcSEcCtD
Amphetamine—Fatigue—Ibandronate—osteoporosis	0.00117	0.00213	CcSEcCtD
Amphetamine—Chest pain—Risedronate—osteoporosis	0.00117	0.00213	CcSEcCtD
Amphetamine—Anxiety—Risedronate—osteoporosis	0.00117	0.00212	CcSEcCtD
Amphetamine—Constipation—Ibandronate—osteoporosis	0.00116	0.00211	CcSEcCtD
Amphetamine—Gastrointestinal pain—Estropipate—osteoporosis	0.00116	0.00211	CcSEcCtD
Amphetamine—Acute coronary syndrome—Estradiol—osteoporosis	0.00116	0.00211	CcSEcCtD
Amphetamine—Decreased appetite—Calcitriol—osteoporosis	0.00116	0.0021	CcSEcCtD
Amphetamine—Myocardial infarction—Estradiol—osteoporosis	0.00115	0.0021	CcSEcCtD
Amphetamine—Dry mouth—Risedronate—osteoporosis	0.00114	0.00208	CcSEcCtD
Amphetamine—Urinary tract infection—Estradiol—osteoporosis	0.00114	0.00208	CcSEcCtD
Amphetamine—Gastrointestinal pain—Alendronate—osteoporosis	0.00114	0.00208	CcSEcCtD
Amphetamine—Infection—Ethinyl Estradiol—osteoporosis	0.00114	0.00208	CcSEcCtD
Amphetamine—Constipation—Calcitriol—osteoporosis	0.00114	0.00207	CcSEcCtD
Amphetamine—Convulsion—Pamidronate—osteoporosis	0.00113	0.00206	CcSEcCtD
Amphetamine—Hypertension—Pamidronate—osteoporosis	0.00113	0.00205	CcSEcCtD
Amphetamine—Tension—Conjugated Estrogens—osteoporosis	0.00113	0.00205	CcSEcCtD
Amphetamine—Urticaria—Estropipate—osteoporosis	0.00113	0.00205	CcSEcCtD
Amphetamine—Gastrointestinal pain—Raloxifene—osteoporosis	0.00112	0.00204	CcSEcCtD
Amphetamine—Diarrhoea—Etidronic acid—osteoporosis	0.00112	0.00204	CcSEcCtD
Amphetamine—Abdominal pain—Estropipate—osteoporosis	0.00112	0.00204	CcSEcCtD
Amphetamine—Body temperature increased—Estropipate—osteoporosis	0.00112	0.00204	CcSEcCtD
Amphetamine—Tremor—Zoledronate—osteoporosis	0.00112	0.00203	CcSEcCtD
Amphetamine—Nervousness—Conjugated Estrogens—osteoporosis	0.00112	0.00203	CcSEcCtD
Amphetamine—Infection—Risedronate—osteoporosis	0.00111	0.00202	CcSEcCtD
Amphetamine—Gastrointestinal pain—Ibandronate—osteoporosis	0.00111	0.00202	CcSEcCtD
Amphetamine—Urticaria—Alendronate—osteoporosis	0.00111	0.00202	CcSEcCtD
Amphetamine—Anxiety—Pamidronate—osteoporosis	0.00111	0.00201	CcSEcCtD
Amphetamine—Abdominal pain—Alendronate—osteoporosis	0.0011	0.00201	CcSEcCtD
Amphetamine—Body temperature increased—Alendronate—osteoporosis	0.0011	0.00201	CcSEcCtD
Amphetamine—Agitation—Zoledronate—osteoporosis	0.0011	0.00199	CcSEcCtD
Amphetamine—Angioedema—Zoledronate—osteoporosis	0.00109	0.00198	CcSEcCtD
Amphetamine—Gastrointestinal pain—Calcitriol—osteoporosis	0.00109	0.00198	CcSEcCtD
Amphetamine—Abdominal pain—Raloxifene—osteoporosis	0.00109	0.00197	CcSEcCtD
Amphetamine—Body temperature increased—Raloxifene—osteoporosis	0.00109	0.00197	CcSEcCtD
Amphetamine—Urticaria—Ibandronate—osteoporosis	0.00108	0.00196	CcSEcCtD
Amphetamine—Abdominal pain—Ibandronate—osteoporosis	0.00108	0.00195	CcSEcCtD
Amphetamine—Body temperature increased—Ibandronate—osteoporosis	0.00108	0.00195	CcSEcCtD
Amphetamine—Anaphylactic shock—Pamidronate—osteoporosis	0.00107	0.00194	CcSEcCtD
Amphetamine—Infection—Pamidronate—osteoporosis	0.00106	0.00192	CcSEcCtD
Amphetamine—Urticaria—Calcitriol—osteoporosis	0.00106	0.00192	CcSEcCtD
Amphetamine—Palpitations—Zoledronate—osteoporosis	0.00105	0.00192	CcSEcCtD
Amphetamine—Body temperature increased—Calcitriol—osteoporosis	0.00105	0.00191	CcSEcCtD
Amphetamine—Abdominal pain—Calcitriol—osteoporosis	0.00105	0.00191	CcSEcCtD
Amphetamine—Angioedema—Conjugated Estrogens—osteoporosis	0.00105	0.00191	CcSEcCtD
Amphetamine—Hypersensitivity—Estropipate—osteoporosis	0.00105	0.0019	CcSEcCtD
Amphetamine—Vomiting—Etidronic acid—osteoporosis	0.00104	0.00189	CcSEcCtD
Amphetamine—Tachycardia—Pamidronate—osteoporosis	0.00104	0.00189	CcSEcCtD
Amphetamine—Rash—Etidronic acid—osteoporosis	0.00103	0.00188	CcSEcCtD
Amphetamine—Convulsion—Zoledronate—osteoporosis	0.00103	0.00188	CcSEcCtD
Amphetamine—Dermatitis—Etidronic acid—osteoporosis	0.00103	0.00188	CcSEcCtD
Amphetamine—Hyperhidrosis—Pamidronate—osteoporosis	0.00103	0.00187	CcSEcCtD
Amphetamine—Hypertension—Zoledronate—osteoporosis	0.00103	0.00187	CcSEcCtD
Amphetamine—Hypersensitivity—Alendronate—osteoporosis	0.00103	0.00187	CcSEcCtD
Amphetamine—Headache—Etidronic acid—osteoporosis	0.00103	0.00187	CcSEcCtD
Amphetamine—Asthenia—Estropipate—osteoporosis	0.00102	0.00185	CcSEcCtD
Amphetamine—Anorexia—Pamidronate—osteoporosis	0.00102	0.00185	CcSEcCtD
Amphetamine—Chest pain—Zoledronate—osteoporosis	0.00102	0.00185	CcSEcCtD
Amphetamine—Palpitations—Conjugated Estrogens—osteoporosis	0.00101	0.00184	CcSEcCtD
Amphetamine—Insomnia—Risedronate—osteoporosis	0.00101	0.00184	CcSEcCtD
Amphetamine—Anxiety—Zoledronate—osteoporosis	0.00101	0.00184	CcSEcCtD
Amphetamine—Asthenia—Alendronate—osteoporosis	0.001	0.00182	CcSEcCtD
Amphetamine—Hypersensitivity—Ibandronate—osteoporosis	0.001	0.00182	CcSEcCtD
Amphetamine—Dyspnoea—Risedronate—osteoporosis	0.001	0.00182	CcSEcCtD
Amphetamine—Erythema multiforme—Estradiol—osteoporosis	0.000998	0.00181	CcSEcCtD
Amphetamine—Convulsion—Conjugated Estrogens—osteoporosis	0.000995	0.00181	CcSEcCtD
Amphetamine—Dry mouth—Zoledronate—osteoporosis	0.000993	0.0018	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000993	0.0018	CcSEcCtD
Amphetamine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000991	0.0018	CcSEcCtD
Amphetamine—Dyspepsia—Risedronate—osteoporosis	0.000987	0.00179	CcSEcCtD
Amphetamine—Constipation—Ethinyl Estradiol—osteoporosis	0.000983	0.00179	CcSEcCtD
Amphetamine—Hypersensitivity—Calcitriol—osteoporosis	0.000981	0.00178	CcSEcCtD
Amphetamine—Chest pain—Conjugated Estrogens—osteoporosis	0.000978	0.00178	CcSEcCtD
Amphetamine—Asthenia—Ibandronate—osteoporosis	0.000976	0.00177	CcSEcCtD
Amphetamine—Anxiety—Conjugated Estrogens—osteoporosis	0.000974	0.00177	CcSEcCtD
Amphetamine—Nausea—Etidronic acid—osteoporosis	0.000974	0.00177	CcSEcCtD
Amphetamine—Anaphylactic shock—Zoledronate—osteoporosis	0.000974	0.00177	CcSEcCtD
Amphetamine—Diarrhoea—Estropipate—osteoporosis	0.000971	0.00176	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000968	0.00176	CcSEcCtD
Amphetamine—Infection—Zoledronate—osteoporosis	0.000967	0.00176	CcSEcCtD
Amphetamine—Fatigue—Risedronate—osteoporosis	0.000967	0.00176	CcSEcCtD
Amphetamine—Insomnia—Pamidronate—osteoporosis	0.000964	0.00175	CcSEcCtD
Amphetamine—Constipation—Risedronate—osteoporosis	0.000959	0.00174	CcSEcCtD
Amphetamine—Diarrhoea—Alendronate—osteoporosis	0.000956	0.00174	CcSEcCtD
Amphetamine—Asthenia—Calcitriol—osteoporosis	0.000955	0.00174	CcSEcCtD
Amphetamine—Dyspnoea—Pamidronate—osteoporosis	0.00095	0.00173	CcSEcCtD
Amphetamine—Tachycardia—Zoledronate—osteoporosis	0.00095	0.00173	CcSEcCtD
Amphetamine—Somnolence—Pamidronate—osteoporosis	0.000947	0.00172	CcSEcCtD
Amphetamine—Hyperhidrosis—Zoledronate—osteoporosis	0.000941	0.00171	CcSEcCtD
Amphetamine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00094	0.00171	CcSEcCtD
Amphetamine—Diarrhoea—Raloxifene—osteoporosis	0.00094	0.00171	CcSEcCtD
Amphetamine—Dyspepsia—Pamidronate—osteoporosis	0.000938	0.0017	CcSEcCtD
Amphetamine—Dizziness—Estropipate—osteoporosis	0.000938	0.0017	CcSEcCtD
Amphetamine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000937	0.0017	CcSEcCtD
Amphetamine—Infection—Conjugated Estrogens—osteoporosis	0.000931	0.00169	CcSEcCtD
Amphetamine—Diarrhoea—Ibandronate—osteoporosis	0.000931	0.00169	CcSEcCtD
Amphetamine—Anorexia—Zoledronate—osteoporosis	0.000928	0.00169	CcSEcCtD
Amphetamine—Decreased appetite—Pamidronate—osteoporosis	0.000926	0.00168	CcSEcCtD
Amphetamine—Dizziness—Alendronate—osteoporosis	0.000924	0.00168	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00092	0.00167	CcSEcCtD
Amphetamine—Fatigue—Pamidronate—osteoporosis	0.000919	0.00167	CcSEcCtD
Amphetamine—Gastrointestinal pain—Risedronate—osteoporosis	0.000917	0.00167	CcSEcCtD
Amphetamine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000915	0.00166	CcSEcCtD
Amphetamine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000913	0.00166	CcSEcCtD
Amphetamine—Constipation—Pamidronate—osteoporosis	0.000911	0.00166	CcSEcCtD
Amphetamine—Diarrhoea—Calcitriol—osteoporosis	0.000911	0.00166	CcSEcCtD
Amphetamine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000909	0.00165	CcSEcCtD
Amphetamine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000909	0.00165	CcSEcCtD
Amphetamine—Dizziness—Raloxifene—osteoporosis	0.000909	0.00165	CcSEcCtD
Amphetamine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000906	0.00165	CcSEcCtD
Amphetamine—Tension—Estradiol—osteoporosis	0.000902	0.00164	CcSEcCtD
Amphetamine—Vomiting—Estropipate—osteoporosis	0.000902	0.00164	CcSEcCtD
Amphetamine—Dizziness—Ibandronate—osteoporosis	0.0009	0.00163	CcSEcCtD
Amphetamine—Rash—Estropipate—osteoporosis	0.000894	0.00163	CcSEcCtD
Amphetamine—Dermatitis—Estropipate—osteoporosis	0.000894	0.00162	CcSEcCtD
Amphetamine—Anorexia—Conjugated Estrogens—osteoporosis	0.000894	0.00162	CcSEcCtD
Amphetamine—Nervousness—Estradiol—osteoporosis	0.000893	0.00162	CcSEcCtD
Amphetamine—Urticaria—Risedronate—osteoporosis	0.000891	0.00162	CcSEcCtD
Amphetamine—Headache—Estropipate—osteoporosis	0.000889	0.00161	CcSEcCtD
Amphetamine—Vomiting—Alendronate—osteoporosis	0.000888	0.00161	CcSEcCtD
Amphetamine—Body temperature increased—Risedronate—osteoporosis	0.000886	0.00161	CcSEcCtD
Amphetamine—Abdominal pain—Risedronate—osteoporosis	0.000886	0.00161	CcSEcCtD
Amphetamine—Rash—Alendronate—osteoporosis	0.000881	0.0016	CcSEcCtD
Amphetamine—Insomnia—Zoledronate—osteoporosis	0.00088	0.0016	CcSEcCtD
Amphetamine—Dermatitis—Alendronate—osteoporosis	0.00088	0.0016	CcSEcCtD
Amphetamine—Headache—Alendronate—osteoporosis	0.000875	0.00159	CcSEcCtD
Amphetamine—Vomiting—Raloxifene—osteoporosis	0.000874	0.00159	CcSEcCtD
Amphetamine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000872	0.00158	CcSEcCtD
Amphetamine—Dyspnoea—Zoledronate—osteoporosis	0.000868	0.00158	CcSEcCtD
Amphetamine—Rash—Raloxifene—osteoporosis	0.000866	0.00157	CcSEcCtD
Amphetamine—Dermatitis—Raloxifene—osteoporosis	0.000866	0.00157	CcSEcCtD
Amphetamine—Somnolence—Zoledronate—osteoporosis	0.000865	0.00157	CcSEcCtD
Amphetamine—Vomiting—Ibandronate—osteoporosis	0.000865	0.00157	CcSEcCtD
Amphetamine—Tremor—Estradiol—osteoporosis	0.000861	0.00156	CcSEcCtD
Amphetamine—Headache—Raloxifene—osteoporosis	0.000861	0.00156	CcSEcCtD
Amphetamine—Rash—Ibandronate—osteoporosis	0.000858	0.00156	CcSEcCtD
Amphetamine—Dermatitis—Ibandronate—osteoporosis	0.000857	0.00156	CcSEcCtD
Amphetamine—Dyspepsia—Zoledronate—osteoporosis	0.000857	0.00156	CcSEcCtD
Amphetamine—Headache—Ibandronate—osteoporosis	0.000852	0.00155	CcSEcCtD
Amphetamine—Insomnia—Conjugated Estrogens—osteoporosis	0.000848	0.00154	CcSEcCtD
Amphetamine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000847	0.00154	CcSEcCtD
Amphetamine—Vomiting—Calcitriol—osteoporosis	0.000847	0.00154	CcSEcCtD
Amphetamine—Decreased appetite—Zoledronate—osteoporosis	0.000846	0.00154	CcSEcCtD
Amphetamine—Agitation—Estradiol—osteoporosis	0.000845	0.00154	CcSEcCtD
Amphetamine—Nausea—Estropipate—osteoporosis	0.000843	0.00153	CcSEcCtD
Amphetamine—Abdominal pain—Pamidronate—osteoporosis	0.000843	0.00153	CcSEcCtD
Amphetamine—Body temperature increased—Pamidronate—osteoporosis	0.000843	0.00153	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00084	0.00153	CcSEcCtD
Amphetamine—Angioedema—Estradiol—osteoporosis	0.00084	0.00153	CcSEcCtD
Amphetamine—Rash—Calcitriol—osteoporosis	0.00084	0.00153	CcSEcCtD
Amphetamine—Fatigue—Zoledronate—osteoporosis	0.000839	0.00153	CcSEcCtD
Amphetamine—Dermatitis—Calcitriol—osteoporosis	0.000839	0.00152	CcSEcCtD
Amphetamine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000836	0.00152	CcSEcCtD
Amphetamine—Headache—Calcitriol—osteoporosis	0.000834	0.00152	CcSEcCtD
Amphetamine—Somnolence—Conjugated Estrogens—osteoporosis	0.000833	0.00151	CcSEcCtD
Amphetamine—Constipation—Zoledronate—osteoporosis	0.000832	0.00151	CcSEcCtD
Amphetamine—Nausea—Alendronate—osteoporosis	0.00083	0.00151	CcSEcCtD
Amphetamine—Hypersensitivity—Risedronate—osteoporosis	0.000826	0.0015	CcSEcCtD
Amphetamine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000825	0.0015	CcSEcCtD
Amphetamine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000825	0.0015	CcSEcCtD
Amphetamine—Nausea—Raloxifene—osteoporosis	0.000816	0.00148	CcSEcCtD
Amphetamine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000815	0.00148	CcSEcCtD
Amphetamine—Palpitations—Estradiol—osteoporosis	0.000812	0.00148	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000809	0.00147	CcSEcCtD
Amphetamine—Fatigue—Conjugated Estrogens—osteoporosis	0.000808	0.00147	CcSEcCtD
Amphetamine—Nausea—Ibandronate—osteoporosis	0.000808	0.00147	CcSEcCtD
Amphetamine—Asthenia—Risedronate—osteoporosis	0.000804	0.00146	CcSEcCtD
Amphetamine—Constipation—Conjugated Estrogens—osteoporosis	0.000802	0.00146	CcSEcCtD
Amphetamine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000796	0.00145	CcSEcCtD
Amphetamine—Hypertension—Estradiol—osteoporosis	0.000794	0.00144	CcSEcCtD
Amphetamine—Nausea—Calcitriol—osteoporosis	0.000791	0.00144	CcSEcCtD
Amphetamine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000787	0.00143	CcSEcCtD
Amphetamine—Hypersensitivity—Pamidronate—osteoporosis	0.000785	0.00143	CcSEcCtD
Amphetamine—Chest pain—Estradiol—osteoporosis	0.000783	0.00142	CcSEcCtD
Amphetamine—Anxiety—Estradiol—osteoporosis	0.00078	0.00142	CcSEcCtD
Amphetamine—Urticaria—Zoledronate—osteoporosis	0.000773	0.00141	CcSEcCtD
Amphetamine—Body temperature increased—Zoledronate—osteoporosis	0.00077	0.0014	CcSEcCtD
Amphetamine—Abdominal pain—Zoledronate—osteoporosis	0.00077	0.0014	CcSEcCtD
Amphetamine—Diarrhoea—Risedronate—osteoporosis	0.000767	0.00139	CcSEcCtD
Amphetamine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000767	0.00139	CcSEcCtD
Amphetamine—Dry mouth—Estradiol—osteoporosis	0.000765	0.00139	CcSEcCtD
Amphetamine—Asthenia—Pamidronate—osteoporosis	0.000765	0.00139	CcSEcCtD
Amphetamine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00076	0.00138	CcSEcCtD
Amphetamine—Anaphylactic shock—Estradiol—osteoporosis	0.00075	0.00136	CcSEcCtD
Amphetamine—Infection—Estradiol—osteoporosis	0.000745	0.00135	CcSEcCtD
Amphetamine—Urticaria—Conjugated Estrogens—osteoporosis	0.000745	0.00135	CcSEcCtD
Amphetamine—Dizziness—Risedronate—osteoporosis	0.000741	0.00135	CcSEcCtD
Amphetamine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000741	0.00135	CcSEcCtD
Amphetamine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000741	0.00135	CcSEcCtD
Amphetamine—Tachycardia—Estradiol—osteoporosis	0.000732	0.00133	CcSEcCtD
Amphetamine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000731	0.00133	CcSEcCtD
Amphetamine—Diarrhoea—Pamidronate—osteoporosis	0.000729	0.00133	CcSEcCtD
Amphetamine—Hyperhidrosis—Estradiol—osteoporosis	0.000725	0.00132	CcSEcCtD
Amphetamine—Rash—Ethinyl Estradiol—osteoporosis	0.000725	0.00132	CcSEcCtD
Amphetamine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000724	0.00132	CcSEcCtD
Amphetamine—Headache—Ethinyl Estradiol—osteoporosis	0.00072	0.00131	CcSEcCtD
Amphetamine—Hypersensitivity—Zoledronate—osteoporosis	0.000717	0.0013	CcSEcCtD
Amphetamine—Vomiting—Risedronate—osteoporosis	0.000713	0.0013	CcSEcCtD
Amphetamine—Rash—Risedronate—osteoporosis	0.000707	0.00128	CcSEcCtD
Amphetamine—Dermatitis—Risedronate—osteoporosis	0.000706	0.00128	CcSEcCtD
Amphetamine—Dizziness—Pamidronate—osteoporosis	0.000705	0.00128	CcSEcCtD
Amphetamine—Headache—Risedronate—osteoporosis	0.000702	0.00128	CcSEcCtD
Amphetamine—Asthenia—Zoledronate—osteoporosis	0.000698	0.00127	CcSEcCtD
Amphetamine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000691	0.00125	CcSEcCtD
Amphetamine—Nausea—Ethinyl Estradiol—osteoporosis	0.000683	0.00124	CcSEcCtD
Amphetamine—Insomnia—Estradiol—osteoporosis	0.000679	0.00123	CcSEcCtD
Amphetamine—Vomiting—Pamidronate—osteoporosis	0.000678	0.00123	CcSEcCtD
Amphetamine—Asthenia—Conjugated Estrogens—osteoporosis	0.000673	0.00122	CcSEcCtD
Amphetamine—Rash—Pamidronate—osteoporosis	0.000672	0.00122	CcSEcCtD
Amphetamine—Dermatitis—Pamidronate—osteoporosis	0.000671	0.00122	CcSEcCtD
Amphetamine—Dyspnoea—Estradiol—osteoporosis	0.000669	0.00122	CcSEcCtD
Amphetamine—Headache—Pamidronate—osteoporosis	0.000668	0.00121	CcSEcCtD
Amphetamine—Somnolence—Estradiol—osteoporosis	0.000667	0.00121	CcSEcCtD
Amphetamine—Diarrhoea—Zoledronate—osteoporosis	0.000666	0.00121	CcSEcCtD
Amphetamine—Nausea—Risedronate—osteoporosis	0.000666	0.00121	CcSEcCtD
Amphetamine—Dyspepsia—Estradiol—osteoporosis	0.00066	0.0012	CcSEcCtD
Amphetamine—Decreased appetite—Estradiol—osteoporosis	0.000652	0.00119	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000648	0.00118	CcSEcCtD
Amphetamine—Fatigue—Estradiol—osteoporosis	0.000647	0.00118	CcSEcCtD
Amphetamine—Dizziness—Zoledronate—osteoporosis	0.000644	0.00117	CcSEcCtD
Amphetamine—Constipation—Estradiol—osteoporosis	0.000642	0.00117	CcSEcCtD
Amphetamine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000641	0.00117	CcSEcCtD
Amphetamine—Nausea—Pamidronate—osteoporosis	0.000633	0.00115	CcSEcCtD
Amphetamine—Dizziness—Conjugated Estrogens—osteoporosis	0.00062	0.00113	CcSEcCtD
Amphetamine—Vomiting—Zoledronate—osteoporosis	0.000619	0.00112	CcSEcCtD
Amphetamine—Rash—Zoledronate—osteoporosis	0.000614	0.00112	CcSEcCtD
Amphetamine—Gastrointestinal pain—Estradiol—osteoporosis	0.000613	0.00111	CcSEcCtD
Amphetamine—Dermatitis—Zoledronate—osteoporosis	0.000613	0.00111	CcSEcCtD
Amphetamine—Headache—Zoledronate—osteoporosis	0.00061	0.00111	CcSEcCtD
Amphetamine—Vomiting—Conjugated Estrogens—osteoporosis	0.000596	0.00108	CcSEcCtD
Amphetamine—Urticaria—Estradiol—osteoporosis	0.000596	0.00108	CcSEcCtD
Amphetamine—Abdominal pain—Estradiol—osteoporosis	0.000593	0.00108	CcSEcCtD
Amphetamine—Body temperature increased—Estradiol—osteoporosis	0.000593	0.00108	CcSEcCtD
Amphetamine—Rash—Conjugated Estrogens—osteoporosis	0.000591	0.00107	CcSEcCtD
Amphetamine—Dermatitis—Conjugated Estrogens—osteoporosis	0.00059	0.00107	CcSEcCtD
Amphetamine—Headache—Conjugated Estrogens—osteoporosis	0.000587	0.00107	CcSEcCtD
Amphetamine—Nausea—Zoledronate—osteoporosis	0.000578	0.00105	CcSEcCtD
Amphetamine—Nausea—Conjugated Estrogens—osteoporosis	0.000557	0.00101	CcSEcCtD
Amphetamine—Hypersensitivity—Estradiol—osteoporosis	0.000553	0.001	CcSEcCtD
Amphetamine—Asthenia—Estradiol—osteoporosis	0.000538	0.000978	CcSEcCtD
Amphetamine—Diarrhoea—Estradiol—osteoporosis	0.000513	0.000933	CcSEcCtD
Amphetamine—Dizziness—Estradiol—osteoporosis	0.000496	0.000901	CcSEcCtD
Amphetamine—Vomiting—Estradiol—osteoporosis	0.000477	0.000867	CcSEcCtD
Amphetamine—Rash—Estradiol—osteoporosis	0.000473	0.00086	CcSEcCtD
Amphetamine—Dermatitis—Estradiol—osteoporosis	0.000473	0.000859	CcSEcCtD
Amphetamine—Headache—Estradiol—osteoporosis	0.00047	0.000854	CcSEcCtD
Amphetamine—Nausea—Estradiol—osteoporosis	0.000446	0.00081	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—WNT1—osteoporosis	0.0004	0.00252	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—PTHLH—osteoporosis	0.000399	0.00251	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MGLL—osteoporosis	0.00039	0.00246	CbGpPWpGaD
Amphetamine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000388	0.00245	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000384	0.00242	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000383	0.00241	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—LRP5—osteoporosis	0.000381	0.0024	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—PTH1R—osteoporosis	0.000378	0.00238	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CALCR—osteoporosis	0.000378	0.00238	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—LRP6—osteoporosis	0.000364	0.0023	CbGpPWpGaD
Amphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000362	0.00228	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—PTHLH—osteoporosis	0.000362	0.00228	CbGpPWpGaD
Amphetamine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000357	0.00225	CbGpPWpGaD
Amphetamine—SLC6A2—NRF2 pathway—AGER—osteoporosis	0.000351	0.00222	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CALCA—osteoporosis	0.000351	0.00221	CbGpPWpGaD
Amphetamine—MAOB—Biological oxidations—POMC—osteoporosis	0.000343	0.00216	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—POMC—osteoporosis	0.000325	0.00205	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—FDPS—osteoporosis	0.000323	0.00204	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PKM—osteoporosis	0.000323	0.00204	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CNR2—osteoporosis	0.00032	0.00202	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CALCA—osteoporosis	0.000319	0.00201	CbGpPWpGaD
Amphetamine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000315	0.00198	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—AGER—osteoporosis	0.000311	0.00196	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—ADCY5—osteoporosis	0.00031	0.00195	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TLN1—osteoporosis	0.000308	0.00194	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PGLS—osteoporosis	0.000307	0.00193	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GPD2—osteoporosis	0.000307	0.00193	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000299	0.00188	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	0.000297	0.00187	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.000297	0.00187	CbGpPWpGaD
Amphetamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000294	0.00185	CbGpPWpGaD
Amphetamine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	0.000293	0.00185	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PNP—osteoporosis	0.00028	0.00177	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ATIC—osteoporosis	0.00028	0.00177	CbGpPWpGaD
Amphetamine—CYP2A6—Biological oxidations—CYP19A1—osteoporosis	0.000278	0.00175	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000277	0.00175	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PKM—osteoporosis	0.000274	0.00173	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—FDPS—osteoporosis	0.000274	0.00173	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—LEP—osteoporosis	0.00027	0.0017	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—P4HB—osteoporosis	0.000265	0.00167	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000265	0.00167	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—AGER—osteoporosis	0.00026	0.00164	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PGLS—osteoporosis	0.000259	0.00164	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GPD2—osteoporosis	0.000259	0.00164	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PTH—osteoporosis	0.000258	0.00163	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000254	0.0016	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—RAP1A—osteoporosis	0.000254	0.0016	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CNR2—osteoporosis	0.000251	0.00159	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—ADCY5—osteoporosis	0.00025	0.00157	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NFATC1—osteoporosis	0.000247	0.00156	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—DKK1—osteoporosis	0.000245	0.00155	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000241	0.00152	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—OXCT1—osteoporosis	0.000238	0.0015	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CA2—osteoporosis	0.000238	0.0015	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PNP—osteoporosis	0.000237	0.0015	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ATIC—osteoporosis	0.000237	0.0015	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—WNT1—osteoporosis	0.000236	0.00149	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—MGLL—osteoporosis	0.000232	0.00147	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—FGA—osteoporosis	0.00023	0.00145	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—ADCY5—osteoporosis	0.000227	0.00143	CbGpPWpGaD
Amphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000218	0.00137	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PTHLH—osteoporosis	0.000214	0.00135	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—BMP2—osteoporosis	0.000214	0.00135	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PTH1R—osteoporosis	0.000214	0.00135	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CALCR—osteoporosis	0.000214	0.00135	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000211	0.00133	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—FGB—osteoporosis	0.000209	0.00132	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PSMA2—osteoporosis	0.000202	0.00127	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PSMA5—osteoporosis	0.000202	0.00127	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—OXCT1—osteoporosis	0.000202	0.00127	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CA2—osteoporosis	0.000202	0.00127	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—PTH—osteoporosis	0.000199	0.00125	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—IDH2—osteoporosis	0.000198	0.00125	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MGLL—osteoporosis	0.000197	0.00124	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PTH1R—osteoporosis	0.000194	0.00122	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CALCR—osteoporosis	0.000194	0.00122	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CNR2—osteoporosis	0.000193	0.00122	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CALCA—osteoporosis	0.000188	0.00119	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CYP27A1—osteoporosis	0.000186	0.00117	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—ADCY5—osteoporosis	0.000185	0.00117	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—POMC—osteoporosis	0.000184	0.00116	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—WNT1—osteoporosis	0.000182	0.00115	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ACP5—osteoporosis	0.000181	0.00114	CbGpPWpGaD
Amphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000176	0.00111	CbGpPWpGaD
Amphetamine—SLC6A4—NRF2 pathway—TGFB1—osteoporosis	0.000173	0.00109	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—KL—osteoporosis	0.000171	0.00108	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—ADCY5—osteoporosis	0.00017	0.00107	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—MGLL—osteoporosis	0.00017	0.00107	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—TPI1—osteoporosis	0.000168	0.00106	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—IDH2—osteoporosis	0.000167	0.00105	CbGpPWpGaD
Amphetamine—CYP2A6—Biological oxidations—POMC—osteoporosis	0.000167	0.00105	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—POMC—osteoporosis	0.000167	0.00105	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000167	0.00105	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—LEP—osteoporosis	0.000165	0.00104	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—PTHLH—osteoporosis	0.000164	0.00104	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL6R—osteoporosis	0.000163	0.00103	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—P4HB—osteoporosis	0.000158	0.000997	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PKM—osteoporosis	0.000158	0.000994	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—FDPS—osteoporosis	0.000158	0.000994	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP27A1—osteoporosis	0.000157	0.000992	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	0.000156	0.000983	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GAPDH—osteoporosis	0.000155	0.000978	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MGLL—osteoporosis	0.000154	0.000972	CbGpPWpGaD
Amphetamine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	0.000154	0.00097	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ACP5—osteoporosis	0.000153	0.000965	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000153	0.000964	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—RAP1A—osteoporosis	0.000151	0.000953	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PGLS—osteoporosis	0.000149	0.000942	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GPD2—osteoporosis	0.000149	0.000942	CbGpPWpGaD
Amphetamine—SLC6A2—NRF2 pathway—TGFB1—osteoporosis	0.000148	0.000936	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CALCA—osteoporosis	0.000145	0.000914	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000144	0.000909	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000144	0.000906	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—TPI1—osteoporosis	0.000142	0.000897	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PNP—osteoporosis	0.000137	0.000862	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ATIC—osteoporosis	0.000137	0.000862	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ADCY5—osteoporosis	0.000134	0.000845	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—P4HB—osteoporosis	0.000134	0.000843	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—TGFB1—osteoporosis	0.000132	0.00083	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GAPDH—osteoporosis	0.000131	0.000828	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SPP1—osteoporosis	0.00013	0.000817	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—RAP1A—osteoporosis	0.000128	0.000806	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SOST—osteoporosis	0.000127	0.000799	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—POMC—osteoporosis	0.000125	0.000789	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000123	0.000778	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ENO1—osteoporosis	0.000122	0.00077	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PSMA2—osteoporosis	0.00012	0.000759	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PSMA5—osteoporosis	0.00012	0.000759	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IRS2—osteoporosis	0.000117	0.000739	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CA2—osteoporosis	0.000116	0.000733	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—OXCT1—osteoporosis	0.000116	0.000733	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—LEP—osteoporosis	0.000115	0.000723	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTH1R—osteoporosis	0.000115	0.000723	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CALCR—osteoporosis	0.000115	0.000723	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MGLL—osteoporosis	0.000113	0.000714	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PTH—osteoporosis	0.000112	0.000708	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000112	0.000707	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	0.00011	0.000693	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ESR1—osteoporosis	0.000109	0.00069	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CNR2—osteoporosis	0.000109	0.00069	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ENO1—osteoporosis	0.000103	0.000652	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IRS1—osteoporosis	0.000102	0.000645	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PTH—osteoporosis	0.000102	0.000643	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PSMA5—osteoporosis	0.000102	0.000642	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PSMA2—osteoporosis	0.000102	0.000642	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—IL6—osteoporosis	0.000101	0.000635	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	9.95e-05	0.000628	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	9.93e-05	0.000626	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CNR2—osteoporosis	9.93e-05	0.000626	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—POMC—osteoporosis	9.85e-05	0.000621	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CYP19A1—osteoporosis	9.76e-05	0.000616	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—IDH2—osteoporosis	9.63e-05	0.000607	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6R—osteoporosis	9.61e-05	0.000606	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IGF1—osteoporosis	9.47e-05	0.000598	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—POMC—osteoporosis	9.37e-05	0.000591	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—WNT1—osteoporosis	9.33e-05	0.000589	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PTHLH—osteoporosis	9.3e-05	0.000586	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MGLL—osteoporosis	9.1e-05	0.000574	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP27A1—osteoporosis	9.05e-05	0.000571	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LRP5—osteoporosis	8.88e-05	0.00056	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PKM—osteoporosis	8.84e-05	0.000557	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—FDPS—osteoporosis	8.84e-05	0.000557	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ACP5—osteoporosis	8.8e-05	0.000555	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LRP6—osteoporosis	8.5e-05	0.000536	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PTHLH—osteoporosis	8.44e-05	0.000533	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PGLS—osteoporosis	8.38e-05	0.000528	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPD2—osteoporosis	8.38e-05	0.000528	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP19A1—osteoporosis	8.26e-05	0.000521	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TPI1—osteoporosis	8.19e-05	0.000516	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CALCA—osteoporosis	8.18e-05	0.000516	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ADCY5—osteoporosis	7.97e-05	0.000503	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GPX1—osteoporosis	7.95e-05	0.000501	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—P4HB—osteoporosis	7.7e-05	0.000485	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ATIC—osteoporosis	7.66e-05	0.000483	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PNP—osteoporosis	7.66e-05	0.000483	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—POMC—osteoporosis	7.58e-05	0.000478	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GAPDH—osteoporosis	7.55e-05	0.000477	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CALCA—osteoporosis	7.43e-05	0.000469	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—RAP1A—osteoporosis	7.36e-05	0.000464	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—MTHFR—osteoporosis	7.33e-05	0.000463	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL6—osteoporosis	7.24e-05	0.000457	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TLN1—osteoporosis	7.17e-05	0.000453	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ADCY5—osteoporosis	6.75e-05	0.000426	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GPX1—osteoporosis	6.72e-05	0.000424	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—OXCT1—osteoporosis	6.51e-05	0.000411	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CA2—osteoporosis	6.51e-05	0.000411	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MGLL—osteoporosis	6.35e-05	0.000401	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MTHFR—osteoporosis	6.21e-05	0.000391	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—P4HB—osteoporosis	6.19e-05	0.00039	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—IL6—osteoporosis	6.16e-05	0.000389	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTH—osteoporosis	6.02e-05	0.00038	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ENO1—osteoporosis	5.95e-05	0.000375	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RAP1A—osteoporosis	5.91e-05	0.000373	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—POMC—osteoporosis	5.87e-05	0.00037	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CNR2—osteoporosis	5.86e-05	0.00037	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PSMA5—osteoporosis	5.86e-05	0.00037	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PSMA2—osteoporosis	5.86e-05	0.00037	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—ADCY5—osteoporosis	5.82e-05	0.000367	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NFATC1—osteoporosis	5.77e-05	0.000364	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DKK1—osteoporosis	5.72e-05	0.000361	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MYC—osteoporosis	5.69e-05	0.000359	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TGFB1—osteoporosis	5.68e-05	0.000358	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—WNT1—osteoporosis	5.51e-05	0.000348	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—IDH2—osteoporosis	5.4e-05	0.000341	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGA—osteoporosis	5.36e-05	0.000338	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—ADCY5—osteoporosis	5.29e-05	0.000333	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP27A1—osteoporosis	5.08e-05	0.00032	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BMP2—osteoporosis	4.99e-05	0.000315	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTHLH—osteoporosis	4.99e-05	0.000315	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—POMC—osteoporosis	4.96e-05	0.000313	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ACP5—osteoporosis	4.94e-05	0.000311	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGB—osteoporosis	4.88e-05	0.000308	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP19A1—osteoporosis	4.75e-05	0.0003	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PSMA2—osteoporosis	4.71e-05	0.000297	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PSMA5—osteoporosis	4.71e-05	0.000297	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TPI1—osteoporosis	4.59e-05	0.00029	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CALCA—osteoporosis	4.39e-05	0.000277	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—P4HB—osteoporosis	4.32e-05	0.000272	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—POMC—osteoporosis	4.28e-05	0.00027	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6—osteoporosis	4.28e-05	0.00027	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GAPDH—osteoporosis	4.24e-05	0.000267	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—RAP1A—osteoporosis	4.13e-05	0.00026	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KL—osteoporosis	3.99e-05	0.000251	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—POMC—osteoporosis	3.89e-05	0.000245	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADCY5—osteoporosis	3.88e-05	0.000245	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GPX1—osteoporosis	3.87e-05	0.000244	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6R—osteoporosis	3.79e-05	0.000239	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MTHFR—osteoporosis	3.57e-05	0.000225	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ENO1—osteoporosis	3.34e-05	0.00021	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PSMA2—osteoporosis	3.29e-05	0.000207	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PSMA5—osteoporosis	3.29e-05	0.000207	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADCY5—osteoporosis	3.12e-05	0.000197	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SPP1—osteoporosis	3.02e-05	0.000191	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—POMC—osteoporosis	2.86e-05	0.00018	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IRS2—osteoporosis	2.73e-05	0.000172	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LEP—osteoporosis	2.67e-05	0.000169	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP19A1—osteoporosis	2.67e-05	0.000168	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ESR1—osteoporosis	2.55e-05	0.000161	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IRS1—osteoporosis	2.39e-05	0.00015	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—POMC—osteoporosis	2.3e-05	0.000145	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6R—osteoporosis	2.24e-05	0.000141	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF1—osteoporosis	2.21e-05	0.000139	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADCY5—osteoporosis	2.18e-05	0.000137	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPX1—osteoporosis	2.17e-05	0.000137	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MTHFR—osteoporosis	2e-05	0.000126	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6—osteoporosis	1.69e-05	0.000107	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—POMC—osteoporosis	1.6e-05	0.000101	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MYC—osteoporosis	1.33e-05	8.38e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFB1—osteoporosis	1.32e-05	8.36e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6—osteoporosis	9.98e-06	6.3e-05	CbGpPWpGaD
